Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art
Eukaryotic elongation factor 1A (eEF1A) canonically delivers amino acyl tRNA to the ribosomal A site during the elongation stage of protein biosynthesis. Yet paradoxically, the oncogenic nature of this instrumental protein has long been recognized. Consistently, eEF1A has proven to be targeted by a...
Main Authors: | Han Zhang, Jiayou Cai, Siqi Yu, Bin Sun, Weicheng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5184 |
Similar Items
-
The eEF1 family of mammalian translation elongation factors
by: B.S. Negrutskii, et al.
Published: (2023-01-01) -
Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy
by: Bin Zhang, et al.
Published: (2021-02-01) -
Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
by: Xuemin Wang, et al.
Published: (2017-11-01) -
Monosomes buffer translational stress to allow for active ribosome elongation
by: Rico Schieweck, et al.
Published: (2023-05-01) -
Eukaryotic Elongation Factor 3 Protects <i>Saccharomyces cerevisiae</i> Yeast from Oxidative Stress
by: Karolina Gościńska, et al.
Published: (2020-11-01)